v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:    
Research and development $ 142,631 $ 101,200
General and administrative 17,692 26,024
Total operating expenses 160,323 127,224
Interest income, net (7,095) (6,337)
Other income, net (4) (1,187)
Loss before provision for income taxes (153,224) (119,700)
Provision for income taxes 0 913
Net loss $ (153,224) $ (120,613)
Net loss per common share - basic (in dollars per share) $ (0.75) $ (0.71)
Net loss per common share - diluted (in dollars per share) $ (0.75) $ (0.71)
Weighted-average common shares outstanding – basic (in shares) 205,545,373 170,872,994
Weighted-average common shares outstanding – diluted (in shares) 205,545,373 170,872,994